FOLH1 and prostate carcinoma: On the whole, these data demonstrate that NK-92/CAR cells are endowed with high and specific antitumor activity against PSMA-expressing prostate cancer cells, and that their viability and functionality is transiently preserved after γ-irradiation at a dose that prevents further effector cell replication but still permits target cell recognition and therapeutic activity in vivo.